Questions and Answers
What is the main objective in treating patients with hypoxemia and hypercapnia?
Oxygen therapy for patients with COPD should maintain resting oxygen saturation at or above 90%.
True
What may excessive oxygen administration in patients lead to?
Retention of carbon dioxide
A SaO2 of ______ or less warrants further evaluation with arterial blood gas analysis.
Signup and view all the answers
What type of bronchodilator may be prescribed for grade I (mild) COPD?
Signup and view all the answers
Long-acting bronchodilators are primarily used for acute management of symptomatic flares.
Signup and view all the answers
What is essential when using a pMDI or DPI?
Signup and view all the answers
Bronchodilators relieve bronchospasm by improving expiratory flow through ______.
Signup and view all the answers
All patients with COPD will respond significantly to short-acting bronchodilators.
Signup and view all the answers
Match the following inhaler types with their characteristics:
Signup and view all the answers
Study Notes
Objectives of Treatment
- Aim to provide sufficient oxygen to improve oxygenation in patients with hypoxemia and hypercapnia.
- In COPD patients, oxygen therapy assists in correcting ventilation–perfusion mismatch.
Oxygen Therapy Guidelines
- Maintain resting oxygen saturation at or above 90%, correlating with a PaO2 of 60 mm Hg or higher.
- Over-administration of oxygen can lead to carbon dioxide retention and respiratory drive suppression.
- Regular monitoring of respiratory rate and pulse oximetry (SpO2) is essential for patients on supplemental oxygen.
- Arterial blood gas analysis is necessary if SaO2 drops to 88% or less.
Factors Affecting Respiratory Drive
- Evaluate for neurological issues, fluid and electrolyte imbalances, and use of opioids or sedatives which can depress respiratory drive.
Pharmacologic Therapy
- Medication regimens for COPD are based on disease severity:
- For grade I (mild), a short-acting bronchodilator is sufficient.
- For grades II and III (moderate to severe), a combination of short-acting and long-acting bronchodilators is prescribed.
- For grades III and IV (severe to very severe), prescribed treatments include long-acting bronchodilators and/or inhaled corticosteroids.
Bronchodilator Therapy
- Essential for symptom management; choice depends on individual response and availability.
- Long-acting bronchodilators are used for maintenance, while short-acting are for acute flare management.
- May relieve bronchospasm by enhancing airflow and promoting lung emptying.
Inhaler Devices
- Common delivery devices are pressurized metered-dose inhalers (pMDIs), dry-powder inhalers (DPIs), and small-volume nebulizers (SVNs).
- pMDIs require coordination between inhalation and actuation, while DPIs rely solely on forceful inhalation.
- Spacers can aid in better drug delivery with pMDIs.
Inhaler Techniques and Considerations
- Proper inhaler technique is crucial; poor technique can lead to ineffective symptom control.
- Assess patient capabilities such as hand strength and inspiratory flow for optimal drug delivery.
- Regular use of bronchodilators does not change disease trajectory but is vital for symptom management.
Small-Volume Nebulizers (SVNs)
- Useful for patients unable to use pMDIs or DPIs due to coordination issues.
- Mist particles from an SVN can penetrate deeper into airways.
- Require a power source and regular maintenance to avoid infection.
Quality and Safety Alerts
- Oxygen therapy must be carefully managed to prevent increased hypercapnia.
- Regular training and education on inhaler use can improve adherence and effectiveness of therapy.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Learn about the objectives and guidelines of oxygen therapy in patients with chronic obstructive pulmonary disease (COPD). Understand how oxygen therapy improves oxygenation and corrects ventilation-perfusion mismatch.
